These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1087232)

  • 81. Bone-marrow lymphocytes in acute lymphoid leukaemia: effect of therapeutic regimes.
    Pushpa V; Till MM; Raynsford G; Hardisty RM
    Biomedicine; 1973 Jan; 19(1):11-5. PubMed ID: 4513753
    [No Abstract]   [Full Text] [Related]  

  • 82. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts.
    Bökkerink JP; Stet EH; De Abreu RA; Damen FJ; Hulscher TW; Bakker MA; van Baal JA
    Biochem Pharmacol; 1993 Apr; 45(7):1455-63. PubMed ID: 7682415
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of prednisolone, vincristine, methotrexate and 6-mercaptopurine vs. 6-mercaptopurine and prednisone maintenance therapy in childhood acute leukemia: a Southwest Oncology Group Study.
    Berry DH; Fernbach DJ; Herson J; Pullen J; Sullivan MP; Vietti TJ
    Cancer; 1980 Sep; 46(5):1098-1103. PubMed ID: 7011531
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Treatment of acute lymphoblastic leukemia.
    Burchenal JH; Dowling MD; Tan CT
    Annu Rev Med; 1972; 23():77-92. PubMed ID: 4118886
    [No Abstract]   [Full Text] [Related]  

  • 85. Immunological rebound after cessation of long-term chemotherapy in acute lymphocytic leukaemia: changes in distribution of T and B cell populations in bone marrow and peripheral blood.
    Sen L; Borella L
    Br J Haematol; 1974 Jul; 27(3):477-87. PubMed ID: 4213175
    [No Abstract]   [Full Text] [Related]  

  • 86. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study.
    Krance RA; Newman EM; Ravindranath Y; Harris MB; Brecher M; Wimmer R; Shuster JJ; Land VJ; Pullen J; Crist W
    Cancer; 1991 Feb; 67(3):550-6. PubMed ID: 1985748
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia.
    Campbell AC; Hersey P; MacLennan IC; Kay HE; Pike MC
    Br Med J; 1973 May; 2(5863):385-8. PubMed ID: 4574043
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of antileukaemic chemotherapy on helper and suppressor activity of T cells on immunoglobulin production by B cells.
    Athanassiades PH; Platts-Mills TA; Asherson GL; Oliver RT
    Eur J Cancer (1965); 1978 Sep; 14(9):971-6. PubMed ID: 309391
    [No Abstract]   [Full Text] [Related]  

  • 89. Effect of methotrexate on the immune response in children with acute lymphatic leukaemia.
    O'Meara A; Headon B; Reen DJ
    Immunopharmacology; 1985 Feb; 9(1):33-8. PubMed ID: 3857220
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Unusual skin rash following withdrawal of oral 6-mercaptopurine in children with leukemia.
    Kirk JA; Rogers M; Menser MA; Bergin M; Dalla-Pozza L; Stevens MM
    Med Pediatr Oncol; 1987; 15(5):281-4. PubMed ID: 3477681
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A colchicine-sensitivity test for leukaemic lymphocytes.
    Schrek R; Messmore HL; Knospe WH; Stefani SS
    Scand J Haematol; 1976 May; 16(5):357-64. PubMed ID: 1085030
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Differences in chemotherapeutic susceptibility of human T-, B-, and non-T-/non-B-lymphocytes in culture.
    Ohnuma T; Arkin H; Holland JF
    Recent Results Cancer Res; 1980; 75():61-7. PubMed ID: 6972072
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cytarabine: cytocidal effect on normal and leukemic lymphocytes. Synergism with x rays and comparison with mechlorethamine.
    Schrek R; Stefani SS
    Exp Mol Pathol; 1976 Feb; 24(1):84-90. PubMed ID: 1253938
    [No Abstract]   [Full Text] [Related]  

  • 94. Influence of prednisone and cytostatics on human blood B-, T- and O-lymphocytes in diseases.
    Jonsson V
    Scand J Haematol; 1975 Sep; 15(2):109-16. PubMed ID: 1081272
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
    Kaftański R
    Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Treatment of acute lymphoid leukemia in children: current regimens and future prospects.
    Brecher ML
    N Y State J Med; 1986 Apr; 86(4):188-96. PubMed ID: 3520409
    [No Abstract]   [Full Text] [Related]  

  • 97. Influence of different cytotoxic drugs on T and B lymphocytes in children with all during remission maintenance therapy.
    Ritter J; Oehme J
    Eur J Pediatr; 1976 Dec; 124(1):37-42. PubMed ID: 1087232
    [TBL] [Abstract][Full Text] [Related]  

  • 98. T and B lymphocytes in leukemia therapy.
    Esber E; DiNicola W; Movassaghi N; Leikin S
    Am J Hematol; 1976; 1(2):211-8. PubMed ID: 1087115
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.